Showing results (201-210 of 639) with videos related to
Sort By:
Pageof 64
Lung Cancer (Amsterdam, Netherlands)|July 4, 2021
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trialArmelle Lavole, Julien Mazieres, Sophie Schneider, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2011
Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymomaDominique Fabre, Elie Fadel, Sacha Mussot, et al.Cancer Treatment Reviews|March 26, 2017
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibitionFrancesco Facchinetti, Giulio Rossi, Emilio Bria, et al.Nature Reviews. Clinical Oncology|October 13, 2021
Tumour burden and efficacy of immune-checkpoint inhibitorsFilippo G Dall'Olio, Aurélien Marabelle, Caroline Caramella, et al.Journal of Surgical Oncology|March 25, 2018
Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?Stéphane Collaud, Bastien Provost, Benjamin Besse, et al.Lung Cancer (Amsterdam, Netherlands)|March 2, 2020
Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancerBenjamin Besse, Pilar Garrido, Alexis B Cortot, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 9, 2017
Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot studyPhilippe Atlan, Mohamed Amine Bayar, Emilie Lanoy, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 13, 2024
Postoperative radiotherapy results in 192 epithelial thymic tumours patients with 10 years of follow-upHugo Lopez, Angela Botticella, Farid Belkhir, et al.Genome Biology|January 5, 2021
Comprehensive integrative profiling of upper tract urothelial carcinomasXiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, et al.Eclinicalmedicine|April 1, 2024
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspectivePaul Gougis, Floriane Jochum, Baptiste Abbar, et al.Pageof 64